Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 864 entries
Sorted by: Best Match Show Resources per page
Stroke: Cortical superficial siderosis absent in CADASIL.

Nature reviews. Neurology

Ridler C.
PMID: 28452354
Nat Rev Neurol. 2017 Jun;13(6):318. doi: 10.1038/nrneurol.2017.67. Epub 2017 Apr 28.

No abstract available.

Cite
Ridler C. Stroke: Cortical superficial siderosis absent in CADASIL. Nat Rev Neurol. 2017;13(6):318doi: 10.1038/nrneurol.2017.67.
Ridler, C. (2017). Stroke: Cortical superficial siderosis absent in CADASIL. Nature reviews. Neurology, 13(6), 318. https://doi.org/10.1038/nrneurol.2017.67
Ridler, Charlotte. "Stroke: Cortical superficial siderosis absent in CADASIL." Nature reviews. Neurology vol. 13,6 (2017): 318. doi: https://doi.org/10.1038/nrneurol.2017.67
Ridler C. Stroke: Cortical superficial siderosis absent in CADASIL. Nat Rev Neurol. 2017 Jun;13(6):318. doi: 10.1038/nrneurol.2017.67. Epub 2017 Apr 28. PMID: 28452354.
Copy Download .nbib Format: NLM
Prion disease: Dramatic increases in blood levels of tau and neurofilament light in patients with prion disease.

Nature reviews. Neurology

Ridler C.
PMID: 29545623
Nat Rev Neurol. 2018 May;14(5):252. doi: 10.1038/nrneurol.2018.34. Epub 2018 Mar 16.

No abstract available.

Cite
Ridler C. Prion disease: Dramatic increases in blood levels of tau and neurofilament light in patients with prion disease. Nat Rev Neurol. 2018;14(5):252doi: 10.1038/nrneurol.2018.34.
Ridler, C. (2018). Prion disease: Dramatic increases in blood levels of tau and neurofilament light in patients with prion disease. Nature reviews. Neurology, 14(5), 252. https://doi.org/10.1038/nrneurol.2018.34
Ridler, Charlotte. "Prion disease: Dramatic increases in blood levels of tau and neurofilament light in patients with prion disease." Nature reviews. Neurology vol. 14,5 (2018): 252. doi: https://doi.org/10.1038/nrneurol.2018.34
Ridler C. Prion disease: Dramatic increases in blood levels of tau and neurofilament light in patients with prion disease. Nat Rev Neurol. 2018 May;14(5):252. doi: 10.1038/nrneurol.2018.34. Epub 2018 Mar 16. PMID: 29545623.
Copy Download .nbib Format: NLM
Peripheral neuropathies: Atypical Charcot-Marie-Tooth disease linked to sphingosine 1-phosphate lyase deficiency.

Nature reviews. Neurology

Wood H.
PMID: 28145445
Nat Rev Neurol. 2017 Feb 01;13(2):67. doi: 10.1038/nrneurol.2017.9.

No abstract available.

Cite
Wood H. Peripheral neuropathies: Atypical Charcot-Marie-Tooth disease linked to sphingosine 1-phosphate lyase deficiency. Nat Rev Neurol. 2017;13(2):67doi: 10.1038/nrneurol.2017.9.
Wood, H. (2017). Peripheral neuropathies: Atypical Charcot-Marie-Tooth disease linked to sphingosine 1-phosphate lyase deficiency. Nature reviews. Neurology, 13(2), 67. https://doi.org/10.1038/nrneurol.2017.9
Wood, Heather. "Peripheral neuropathies: Atypical Charcot-Marie-Tooth disease linked to sphingosine 1-phosphate lyase deficiency." Nature reviews. Neurology vol. 13,2 (2017): 67. doi: https://doi.org/10.1038/nrneurol.2017.9
Wood H. Peripheral neuropathies: Atypical Charcot-Marie-Tooth disease linked to sphingosine 1-phosphate lyase deficiency. Nat Rev Neurol. 2017 Feb 01;13(2):67. doi: 10.1038/nrneurol.2017.9. PMID: 28145445.
Copy Download .nbib Format: NLM
Epilepsy: Electrophysiology elucidates epileptiform activity.

Nature reviews. Neurology

Chase A.
PMID: 24934138
Nat Rev Neurol. 2014 Jul;10(7):363. doi: 10.1038/nrneurol.2014.106. Epub 2014 Jun 17.

No abstract available.

Cite
Chase A. Epilepsy: Electrophysiology elucidates epileptiform activity. Nat Rev Neurol. 2014;10(7):363doi: 10.1038/nrneurol.2014.106.
Chase, A. (2014). Epilepsy: Electrophysiology elucidates epileptiform activity. Nature reviews. Neurology, 10(7), 363. https://doi.org/10.1038/nrneurol.2014.106
Chase, Alex. "Epilepsy: Electrophysiology elucidates epileptiform activity." Nature reviews. Neurology vol. 10,7 (2014): 363. doi: https://doi.org/10.1038/nrneurol.2014.106
Chase A. Epilepsy: Electrophysiology elucidates epileptiform activity. Nat Rev Neurol. 2014 Jul;10(7):363. doi: 10.1038/nrneurol.2014.106. Epub 2014 Jun 17. PMID: 24934138.
Copy Download .nbib Format: NLM
Multiple sclerosis: Spinal cord MRI reveals progression-related MS pathology.

Nature reviews. Neurology

Chase A.
PMID: 25048659
Nat Rev Neurol. 2014 Aug;10(8):425. doi: 10.1038/nrneurol.2014.127. Epub 2014 Jul 22.

No abstract available.

Cite
Chase A. Multiple sclerosis: Spinal cord MRI reveals progression-related MS pathology. Nat Rev Neurol. 2014;10(8):425doi: 10.1038/nrneurol.2014.127.
Chase, A. (2014). Multiple sclerosis: Spinal cord MRI reveals progression-related MS pathology. Nature reviews. Neurology, 10(8), 425. https://doi.org/10.1038/nrneurol.2014.127
Chase, Alex. "Multiple sclerosis: Spinal cord MRI reveals progression-related MS pathology." Nature reviews. Neurology vol. 10,8 (2014): 425. doi: https://doi.org/10.1038/nrneurol.2014.127
Chase A. Multiple sclerosis: Spinal cord MRI reveals progression-related MS pathology. Nat Rev Neurol. 2014 Aug;10(8):425. doi: 10.1038/nrneurol.2014.127. Epub 2014 Jul 22. PMID: 25048659.
Copy Download .nbib Format: NLM
Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.

Nature reviews. Neurology

van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA.
PMID: 25023340
Nat Rev Neurol. 2014 Aug;10(8):469-82. doi: 10.1038/nrneurol.2014.121. Epub 2014 Jul 15.

Guillain-Barré syndrome (GBS) is a potentially life-threatening postinfectious disease characterized by rapidly progressive, symmetrical weakness of the extremities. About 25% of patients develop respiratory insufficiency and many show signs of autonomic dysfunction. Diagnosis can usually be made on clinical...

Cite
van den Berg B, Walgaard C, Drenthen J, et al. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469-82doi: 10.1038/nrneurol.2014.121.
van den Berg, B., Walgaard, C., Drenthen, J., Fokke, C., Jacobs, B. C., & van Doorn, P. A. (2014). Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nature reviews. Neurology, 10(8), 469-82. https://doi.org/10.1038/nrneurol.2014.121
van den Berg, Bianca, et al. "Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis." Nature reviews. Neurology vol. 10,8 (2014): 469-82. doi: https://doi.org/10.1038/nrneurol.2014.121
van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014 Aug;10(8):469-82. doi: 10.1038/nrneurol.2014.121. Epub 2014 Jul 15. PMID: 25023340.
Copy Download .nbib Format: NLM
Headache: Headache disorders may be a harbinger of hypothyroidism.

Nature reviews. Neurology

Wood H.
PMID: 27713490
Nat Rev Neurol. 2016 Nov;12(11):615. doi: 10.1038/nrneurol.2016.156. Epub 2016 Oct 07.

No abstract available.

Cite
Wood H. Headache: Headache disorders may be a harbinger of hypothyroidism. Nat Rev Neurol. 2016;12(11):615doi: 10.1038/nrneurol.2016.156.
Wood, H. (2016). Headache: Headache disorders may be a harbinger of hypothyroidism. Nature reviews. Neurology, 12(11), 615. https://doi.org/10.1038/nrneurol.2016.156
Wood, Heather. "Headache: Headache disorders may be a harbinger of hypothyroidism." Nature reviews. Neurology vol. 12,11 (2016): 615. doi: https://doi.org/10.1038/nrneurol.2016.156
Wood H. Headache: Headache disorders may be a harbinger of hypothyroidism. Nat Rev Neurol. 2016 Nov;12(11):615. doi: 10.1038/nrneurol.2016.156. Epub 2016 Oct 07. PMID: 27713490.
Copy Download .nbib Format: NLM
Alzheimer disease: Elevated neurogranin levels reveal early synaptic damage in APOE* ɛ4 carriers.

Nature reviews. Neurology

[No authors listed]
PMID: 27364747
Nat Rev Neurol. 2016 Aug;12(8):430. doi: 10.1038/nrneurol.2016.102. Epub 2016 Jul 01.

No abstract available.

Cite
Alzheimer disease: Elevated neurogranin levels reveal early synaptic damage in APOE* ɛ4 carriers. Nat Rev Neurol. 2016;12(8):430doi: 10.1038/nrneurol.2016.102.
(2016). Alzheimer disease: Elevated neurogranin levels reveal early synaptic damage in APOE* ɛ4 carriers. Nature reviews. Neurology, 12(8), 430. https://doi.org/10.1038/nrneurol.2016.102
"Alzheimer disease: Elevated neurogranin levels reveal early synaptic damage in APOE* ɛ4 carriers." Nature reviews. Neurology vol. 12,8 (2016): 430. doi: https://doi.org/10.1038/nrneurol.2016.102
Alzheimer disease: Elevated neurogranin levels reveal early synaptic damage in APOE* ɛ4 carriers. Nat Rev Neurol. 2016 Aug;12(8):430. doi: 10.1038/nrneurol.2016.102. Epub 2016 Jul 01. PMID: 27364747.
Copy Download .nbib Format: NLM
Neurodevelopmental disorders: Epilepsy and autism spectrum disorders may have a shared aetiology.

Nature reviews. Neurology

[No authors listed]
PMID: 27364744
Nat Rev Neurol. 2016 Aug;12(8):430. doi: 10.1038/nrneurol.2016.100. Epub 2016 Jul 01.

No abstract available.

Cite
Neurodevelopmental disorders: Epilepsy and autism spectrum disorders may have a shared aetiology. Nat Rev Neurol. 2016;12(8):430doi: 10.1038/nrneurol.2016.100.
(2016). Neurodevelopmental disorders: Epilepsy and autism spectrum disorders may have a shared aetiology. Nature reviews. Neurology, 12(8), 430. https://doi.org/10.1038/nrneurol.2016.100
"Neurodevelopmental disorders: Epilepsy and autism spectrum disorders may have a shared aetiology." Nature reviews. Neurology vol. 12,8 (2016): 430. doi: https://doi.org/10.1038/nrneurol.2016.100
Neurodevelopmental disorders: Epilepsy and autism spectrum disorders may have a shared aetiology. Nat Rev Neurol. 2016 Aug;12(8):430. doi: 10.1038/nrneurol.2016.100. Epub 2016 Jul 01. PMID: 27364744.
Copy Download .nbib Format: NLM
Neuromuscular disease: Methotrexate has no steroid-sparing effect in patients with generalized myasthenia gravis.

Nature reviews. Neurology

[No authors listed]
PMID: 27364745
Nat Rev Neurol. 2016 Aug;12(8):430. doi: 10.1038/nrneurol.2016.103. Epub 2016 Jul 01.

No abstract available.

Cite
Neuromuscular disease: Methotrexate has no steroid-sparing effect in patients with generalized myasthenia gravis. Nat Rev Neurol. 2016;12(8):430doi: 10.1038/nrneurol.2016.103.
(2016). Neuromuscular disease: Methotrexate has no steroid-sparing effect in patients with generalized myasthenia gravis. Nature reviews. Neurology, 12(8), 430. https://doi.org/10.1038/nrneurol.2016.103
"Neuromuscular disease: Methotrexate has no steroid-sparing effect in patients with generalized myasthenia gravis." Nature reviews. Neurology vol. 12,8 (2016): 430. doi: https://doi.org/10.1038/nrneurol.2016.103
Neuromuscular disease: Methotrexate has no steroid-sparing effect in patients with generalized myasthenia gravis. Nat Rev Neurol. 2016 Aug;12(8):430. doi: 10.1038/nrneurol.2016.103. Epub 2016 Jul 01. PMID: 27364745.
Copy Download .nbib Format: NLM
RAPID MRI analysis may speed up selection for tPA therapy.

Nature reviews. Neurology

Parekh V.
PMID: 21654709
Nat Rev Neurol. 2011 Jun 08;7(6):300. doi: 10.1038/nrneurol.2011.67.

No abstract available.

Cite
Parekh V. RAPID MRI analysis may speed up selection for tPA therapy. Nat Rev Neurol. 2011;7(6):300doi: 10.1038/nrneurol.2011.67.
Parekh, V. (2011). RAPID MRI analysis may speed up selection for tPA therapy. Nature reviews. Neurology, 7(6), 300. https://doi.org/10.1038/nrneurol.2011.67
Parekh, Vanisha. "RAPID MRI analysis may speed up selection for tPA therapy." Nature reviews. Neurology vol. 7,6 (2011): 300. doi: https://doi.org/10.1038/nrneurol.2011.67
Parekh V. RAPID MRI analysis may speed up selection for tPA therapy. Nat Rev Neurol. 2011 Jun 08;7(6):300. doi: 10.1038/nrneurol.2011.67. PMID: 21654709.
Copy Download .nbib Format: NLM
Multiple sclerosis: HLA B*44 is protective in multiple sclerosis.

Nature reviews. Neurology

Jones N.
PMID: 21105232
Nat Rev Neurol. 2010 Nov;6(11):584. doi: 10.1038/nrneurol.2010.151.

No abstract available.

Cite
Jones N. Multiple sclerosis: HLA B*44 is protective in multiple sclerosis. Nat Rev Neurol. 2010;6(11):584doi: 10.1038/nrneurol.2010.151.
Jones, N. (2010). Multiple sclerosis: HLA B*44 is protective in multiple sclerosis. Nature reviews. Neurology, 6(11), 584. https://doi.org/10.1038/nrneurol.2010.151
Jones, Nick. "Multiple sclerosis: HLA B*44 is protective in multiple sclerosis." Nature reviews. Neurology vol. 6,11 (2010): 584. doi: https://doi.org/10.1038/nrneurol.2010.151
Jones N. Multiple sclerosis: HLA B*44 is protective in multiple sclerosis. Nat Rev Neurol. 2010 Nov;6(11):584. doi: 10.1038/nrneurol.2010.151. PMID: 21105232.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 864 entries